AVEO Pharma (AVEO) Blows Up Q1 Views
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) reported Q1 EPS of $2.28, $2.98 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $133.61 million versus the consensus estimate of $6.28 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First Advantage Corporation (FA) Tops Q2 EPS by 6c ; Offers Guidance
- Park-Ohio Holdings (PKOH) Tops Q2 EPS by 11c; raises guidance
- Enerflex (EFXT) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
